Dr. Archin – Simmons Scholars
News, Trainee & Faculty Initiatives
UNC researchers led by Nancie Archin, PhD, and David Margolis, MD, have shown that interval dosing of the drug Vorinostat reverses HIV latency and is well-tolerated in people living with HIV. However, while Vorinostat makes latent HIV easier to detect, it does not clear or deplete infection, meaning additional advances will be needed to achieve a cure. These results were published in the Journal of Clinical Investigation on July 17.